CORONA Remedies to Participate in Ambit & 360 ONE Investor Conferences
CORONA Remedies Limited officials will attend the "Ambit India Access - Titans of Tomorrow" conference on May 26, 2026, and the "TRINITY INDIA 2026" conference on May 27, 2026. Both events will be held in Mumbai and will focus on publicly available information.
The announcement pertains to scheduled investor meetings where only publicly available information will be discussed, thus having a minimal direct impact on the company's operations or stock.
The announcement is a routine disclosure of participation in investor events and does not contain any new financial information or significant business updates.
CORONA Remedies Limited announced its participation in two upcoming investor conferences. The first event, "Ambit India Access - Titans of Tomorrow," will be hosted by Ambit Capital Group and will take place in Mumbai on Tuesday, May 26, 2026, starting at 10:00 A.M. IST. The second conference, "TRINITY INDIA 2026," will be hosted by 360 ONE Capital (B&K) Group, also in Mumbai, on Wednesday, May 27, 2026, commencing at 10:00 A.M. IST.
Both meetings will be conducted in-person and will involve one-on-one discussions. The company has emphasized that discussions will be based solely on publicly available information, and no unpublished price-sensitive information (UPSI) will be disclosed during these conferences. Management has also noted that the schedule for these events may be subject to change due to unforeseen circumstances.
This intimation is in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement is also available on the company's website, www.coronaremedies.com.
What to do with a filing like this
CORONA Remedies Limited filed this with the NSE as a statutory disclosure, categorised under investor meet intimation. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by CORONA Remedies Limited. Read the original for the full detail.